25.66

7.72% 1.84

After Hours: 25.80 0.14 +0.55%

Tourmaline Bio Inc (TRML)

Overview News Price History Financials Discussions Forecast

Tourmaline Bio Inc stock is traded at $25.66, with a volume of 199.17K. It is up +7.72% in the last 24 hours and down -3.50% over the past month. Tourmaline Bio Inc is a late-stage clinical biotechnology company driven by its mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune diseases. Its initial product candidate is TOUR006, a fully human monoclonal antibody that selectively binds to interleukin-6 (IL-6), a key proinflammatory cytokine involved in the pathogenesis of many autoimmune and inflammatory disorders. The anti-IL-6 and anti-IL-6 receptor (IL-6R) antibody class (IL-6 class) has over two decades of clinical and commercial experience treating over a million patients with a variety of autoimmune and inflammatory diseases.

Previous Close:

$23.82

Open:

$24.06

24h Volume:

199.17K

Relative Volume:

0.88

Market Cap:

$628.89M

Revenue:

Net Income/Loss:

$11.77M

P/E Ratio:

-165.87

EPS:

-0.1547

Net Cash Flow:

$-19.23M

1W Performance:

+6.92%

1M Performance:

-3.50%

6M Performance:

+90.78%

1Y Performance:

+34.06%

1-Day Range:

$23.82

$26.78

1-Week Range:

$22.21

$26.78

52-Week Range:

$12.12

$48.31

Tourmaline Bio Inc Stock (TRML) Company Profile

Name

Tourmaline Bio Inc

Sector

Healthcare (1200)

Industry

Biotechnology (682)

Phone

646-481-9832

Address

27 WEST 24TH STREET, NEW YORK

Employee

Twitter

Next Earnings Date

2024-11-12

Latest SEC Filings

TRML's Discussions on Twitter

Compare TRML with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
TRML Tourmaline Bio Inc	25.66	628.89M	0	11.77M	-19.23M	-0.1547
VRTX Vertex Pharmaceuticals Inc	464.56	119.70B	10.63B	-479.80M	-1.35B	13.33
REGN Regeneron Pharmaceuticals Inc	754.87	82.75B	13.85B	4.65B	3.32B	35.06
ARGX Argen X Se Adr	614.59	36.73B	1.86B	-40.29M	-1.28B	-4.16
ALNY Alnylam Pharmaceuticals Inc	253.74	32.53B	2.09B	-332.26M	16.06M	-4.14
BNTX Biontech Se Adr	120.72	28.50B	3.30B	-501.07M	1.03B	11.54

Tourmaline Bio Inc Stock (TRML) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-11-24	Reiterated	H.C. Wainwright	Buy
Dec-15-23	Initiated	Jefferies	Buy
Dec-04-23	Resumed	H.C. Wainwright	Buy
Nov-17-23	Initiated	Truist	Buy
Oct-31-23	Initiated	Guggenheim	Buy
Oct-25-23	Initiated	Piper Sandler	Overweight
Oct-20-22	Initiated	H.C. Wainwright	Buy
Jul-05-22	Downgrade	Morgan Stanley	Overweight → Equal-Weight

View All

Tourmaline Bio Inc Stock (TRML) Latest News

Nov 22, 2024

Jennison Associates LLC Has $29.62 Million Position in Tourmaline Bio, Inc. (NASDAQ:TRML) - MarketBeat

Nov 22, 2024

Nov 18, 2024

Prevent Blindness Declares Fifth Annual Thyroid Eye Disease Awareness Week as Nov. 18-24, 2024 - InvisionMag

Nov 18, 2024

Nov 17, 2024

This Week in Ophthalmology: Week of November 11, 2024 - Ophthalmology Times

Nov 17, 2024

Nov 15, 2024

Blue Owl Capital Holdings LP Adjusts Stake in Tourmaline Bio Inc - GuruFocus.com

Nov 15, 2024

HC Wainwright Reduces Earnings Estimates for Tourmaline Bio - Defense World

Nov 15, 2024

Nov 14, 2024

HC Wainwright Lowers Earnings Estimates for Tourmaline Bio - MarketBeat

Nov 14, 2024

Tourmaline Bio to Host Investor Day on Tuesday, December 10, 2024 - The Manila Times

Nov 14, 2024

Tourmaline Bio Sets Key Investor Day with Focus on Pacibekitug Development | TRML Stock News - StockTitan

Nov 14, 2024

Alternus Clean Energy Inc (NASDAQ:ALCE) Sees Significant Decrease in Short Interest - Defense World

Nov 14, 2024

Alchemy Investments Acquisition Corp 1 (NASDAQ:ALCY) Short Interest Update - Defense World

Nov 14, 2024

Short Interest in Alchemy Investments Acquisition Corp 1 (NASDAQ:ALCYW) Decreases By 97.6% - Defense World

Nov 14, 2024

Greenlane Renewables (OTCMKTS:GRNWF) Trading 21.2% Higher – Here’s What Happened - Defense World

Nov 14, 2024

Nov 13, 2024

Global Healthcare & Medical Tourism News - Medical Tourism Magazine

Nov 13, 2024

Nov 12, 2024

Tourmaline Bio ATM - SVB Leerink

Nov 12, 2024

Varonis Systems, Inc. (NASDAQ:VRNS) Given Average Rating of “Moderate Buy” by Analysts - Defense World

Nov 12, 2024

Tourmaline stock PT nudged by H.C. Wainwright, citing confidence in pacibekitug - Investing.com UK

Nov 12, 2024

Nov 11, 2024

Tourmaline Bio, Inc. Reports Third Quarter Financial Results - TipRanks

Nov 11, 2024

Tourmaline Bio (NASDAQ:TRML) Price Target Raised to $49.00 at HC Wainwright - MarketBeat

Nov 11, 2024

Nov 07, 2024